215 related articles for article (PubMed ID: 29747487)
1. Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same.
Sahu V; Nigam L; Agnihotri V; Gupta A; Shekhar S; Subbarao N; Bhaskar S; Dey S
Cancer Res Treat; 2019 Jan; 51(1):313-325. PubMed ID: 29747487
[TBL] [Abstract][Full Text] [Related]
2. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
[TBL] [Abstract][Full Text] [Related]
3. Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38alpha MAP kinase.
Gill K; Singh AK; Kapoor V; Nigam L; Kumar R; Holla P; Das SN; Yadav S; Subbarao N; Mohanti BK; Dey S
Biochim Biophys Acta; 2013 Mar; 1830(3):2763-9. PubMed ID: 23238519
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of p38β, p38γ, and p38δ and its biological roles in esophageal squamous cell carcinoma.
Zheng S; Yang C; Liu T; Liu Q; Dai F; Sheyhidin I; Lu X
Tumour Biol; 2016 Jun; 37(6):7255-66. PubMed ID: 26666822
[TBL] [Abstract][Full Text] [Related]
5. Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases.
Ruiz-Bonilla V; Perdiguero E; Gresh L; Serrano AL; Zamora M; Sousa-Victor P; Jardí M; Wagner EF; Muñoz-Cánoves P
Cell Cycle; 2008 Jul; 7(14):2208-14. PubMed ID: 18641461
[TBL] [Abstract][Full Text] [Related]
6. Loss of p38δ mitogen-activated protein kinase expression promotes oesophageal squamous cell carcinoma proliferation, migration and anchorage-independent growth.
O'Callaghan C; Fanning LJ; Houston A; Barry OP
Int J Oncol; 2013 Aug; 43(2):405-15. PubMed ID: 23722928
[TBL] [Abstract][Full Text] [Related]
7. The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.
Gill K; Nigam L; Singh R; Kumar S; Subbarao N; Chauhan SS; Dey S
PLoS One; 2014; 9(7):e101525. PubMed ID: 24983631
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of p38α mitogen-activated protein kinase inhibitors through 3D-QSAR and molecular dynamics simulations.
Chang HW; Chung FS; Yang CN
J Chem Inf Model; 2013 Jul; 53(7):1775-86. PubMed ID: 23808966
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α.
Ferrari G; Terushkin V; Wolff MJ; Zhang X; Valacca C; Poggio P; Pintucci G; Mignatti P
Mol Cancer Res; 2012 May; 10(5):605-14. PubMed ID: 22522454
[TBL] [Abstract][Full Text] [Related]
10. P38 kinase in gastrointestinal cancers.
Phan T; Zhang XH; Rosen S; Melstrom LG
Cancer Gene Ther; 2023 Sep; 30(9):1181-1189. PubMed ID: 37248432
[TBL] [Abstract][Full Text] [Related]
11. Assessment of p38α in peripheral blood mononuclear cells (PBMC): a potential blood protein marker of head and neck squamous cell carcinoma.
Gill K; Kumar R; Mohanti BK; Dey S
Clin Transl Oncol; 2013 Nov; 15(11):969-73. PubMed ID: 23553334
[TBL] [Abstract][Full Text] [Related]
12. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.
Leelahavanichkul K; Amornphimoltham P; Molinolo AA; Basile JR; Koontongkaew S; Gutkind JS
Mol Oncol; 2014 Feb; 8(1):105-18. PubMed ID: 24216180
[TBL] [Abstract][Full Text] [Related]
13. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells.
Wang L; Ma R; Flavell RA; Choi ME
J Biol Chem; 2002 Dec; 277(49):47257-62. PubMed ID: 12374793
[TBL] [Abstract][Full Text] [Related]
14. Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells.
Uddin S; Ah-Kang J; Ulaszek J; Mahmud D; Wickrema A
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):147-52. PubMed ID: 14694199
[TBL] [Abstract][Full Text] [Related]
15. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo.
Kuma Y; Sabio G; Bain J; Shpiro N; Márquez R; Cuenda A
J Biol Chem; 2005 May; 280(20):19472-9. PubMed ID: 15755732
[TBL] [Abstract][Full Text] [Related]
16. Gene structure, molecular characterization and transcriptional expression of two p38 isoforms (MAPK11 and MAPK14) from rock bream (Oplegnathus fasciatus).
Umasuthan N; Bathige SD; Noh JK; Lee J
Fish Shellfish Immunol; 2015 Nov; 47(1):331-43. PubMed ID: 26363230
[TBL] [Abstract][Full Text] [Related]
17. Comparative chemical array screening for p38γ/δ MAPK inhibitors using a single gatekeeper residue difference between p38α/β and p38γ/δ.
Kondoh Y; Honda K; Hiranuma S; Hayashi T; Shimizu T; Watanabe N; Osada H
Sci Rep; 2016 Jul; 6():29881. PubMed ID: 27431267
[TBL] [Abstract][Full Text] [Related]
18. MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation.
Romero-Becerra R; Mora A; Manieri E; Nikolic I; Santamans AM; Montalvo-Romeral V; Cruz FM; Rodríguez E; León M; Leiva-Vega L; Sanz L; Bondía V; Filgueiras-Rama D; Jiménez-Borreguero LJ; Jalife J; Gonzalez-Teran B; Sabio G
Elife; 2022 Aug; 11():. PubMed ID: 35971771
[TBL] [Abstract][Full Text] [Related]
19. Mouse embryonic stem cells lacking p38alpha and p38delta can differentiate to endothelial cells, smooth muscle cells, and epithelial cells.
Chakraborty S; Kang B; Huang F; Guo YL
Differentiation; 2009; 78(2-3):143-50. PubMed ID: 19539422
[TBL] [Abstract][Full Text] [Related]
20. Novel strategies for inhibition of the p38 MAPK pathway.
Zhang J; Shen B; Lin A
Trends Pharmacol Sci; 2007 Jun; 28(6):286-95. PubMed ID: 17482683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
